| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.81▼ | 9.79▼ | 9.78▼ | 9.90▼ | 9.81▼ |
| MA10 | 9.82▼ | 9.79▼ | 9.84▼ | 9.89▼ | 10.05▼ |
| MA20 | 9.82▼ | 9.86▼ | 9.83▼ | 9.81▼ | 9.72▼ |
| MA50 | 9.80▼ | 9.84▼ | 9.91▼ | 10.08▼ | 7.05▲ |
| MA100 | 9.88▼ | 9.91▼ | 9.77▼ | 9.40▲ | 8.51▲ |
| MA200 | 9.83▼ | 9.77▼ | 9.94▼ | 7.46▲ | 9.21▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.010▼ | -0.014▼ | 0.022▲ | -0.159▼ |
| RSI | 37.003▼ | 42.344▼ | 42.541▼ | 46.950▼ | 55.979▲ |
| STOCH | 26.977 | 50.128 | 34.784 | 64.586 | 28.892 |
| WILL %R | -92.683▼ | -82.432▼ | -84.337▼ | -45.172 | -72.849 |
| CCI | -264.187▼ | -61.122 | -93.814 | 22.336 | -75.028 |
|
Thursday, January 22, 2026 03:02 PM
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline includes ...
|
|
Thursday, January 15, 2026 05:29 AM
A look at the shareholders of Immatics N.V. (NASDAQ:IMTX) can tell us which group is most powerful. And the group that holds the biggest piece of the pie are institutions with 38% ownership. Put ...
|
|
Friday, December 05, 2025 03:00 AM
Houston, Texas and Tuebingen, Germany, December 05, 2025 – Immatics N.V. (IMTX) (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 10.02 | 10.10 | 9.58 | 9.70 | 249,442 |
| 27/01/26 | 9.71 | 10.07 | 9.68 | 9.99 | 206,123 |
| 26/01/26 | 9.83 | 9.87 | 9.37 | 9.73 | 276,646 |
| 23/01/26 | 10.10 | 10.14 | 9.76 | 9.91 | 285,010 |
| 22/01/26 | 10.06 | 10.355 | 9.99 | 10.15 | 372,841 |
| 21/01/26 | 9.86 | 10.12 | 9.72 | 9.98 | 267,010 |
| 20/01/26 | 9.64 | 10.14 | 9.55 | 9.87 | 284,526 |
| 16/01/26 | 9.94 | 10.14 | 9.56 | 9.83 | 454,229 |
| 15/01/26 | 9.89 | 10.205 | 9.83 | 9.92 | 311,593 |
| 14/01/26 | 9.40 | 9.94 | 9.34 | 9.83 | 377,483 |
|
|
||||
|
|
||||
|
|